The P/B multiple of 0.04 is far below peers like QFIN (0.33) and FINV (0.39), suggesting the market views Lufax's equity as impaired rather than a going-concern franchise. This valuation implies a negative return on tangible equity expectation, consistent with the reported negative ROE and NIM, and indicates investors are pricing the company for further balance sheet deterioration rather than a turnaround.

The persistent negative ROE is driven by a combination of negative net interest margins and substantial credit impairment provisions that overwhelm any fee income. This is not a cyclical downturn but a structural outcome of the risk-bearing model transition, where the cost of risk exceeds the yield on assets, making the core lending economics unprofitable.

The negative NIM confirms that funding costs now exceed asset yields, a critical failure for any financial institution. The erratic efficiency ratio, swinging from 33% to 140% and back to 92%, suggests extreme volatility in operating expenses relative to a shrinking revenue base, pointing to a high fixed-cost structure that cannot be scaled down quickly enough.

While the 40% equity ratio is well above typical bank minimums, it is misleading because the denominator (total assets) is contracting due to loan runoff. The more telling metric is the absolute decline in shareholders' equity from $93.3B to $79.0B, which directly reduces the loss-absorption buffer. This trend suggests the capital base is being consumed by operating losses and provisions, not strengthened.

The magnitude of provisions relative to equity is alarming and suggests that the risk-bearing model is generating losses at a rate that could rapidly erode the remaining capital buffer. This level of provisioning indicates that the underlying collateral or borrower quality in the SBO segment is deteriorating significantly, warranting close monitoring of delinquency trends.